AEGEA Medical Secures $36,000,000 Series C Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5c154f2d-36e7-4495-8f3b-c4a4da1abff8 - Date
5/4/2015 - Company Name
AEGEA Medical - Mailing Address
2686 Middlefield Rd Redwood City, CA 94063 USA - Company Description
AEGEA Medical is a private, clinical-stage medical device company that is developing a novel treatment for abnormal uterine bleeding. The company’s products are not available for sale in the United States. - Website
http://www.aegeamedical.com - Transaction Type
Venture Equity - Transaction Amount
$36,000,000 - Transaction Round
Series C - Proceeds Purposes
AEGEA will use this Series C capital to complete the submission of its PMA application to seek FDA approval to market its endometrial ablation procedure to treat abnormal uterine bleeding. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
